Outcomes of temporary mechanical circulatory support in cardiogenic shock due to end-stage heart failure.

ABSTRACT:

Background

There are few reports of mechanical circulatory support (MCS) in patients with cardiogenic shock (CS) due to end-stage heart failure (ESHF). We evaluated our institutional MCS strategy and compared the outcomes of INTERMACS 1 and 2 patients with CS due to ESHF.

Methods

Retrospective analysis of prospectively collected data (November 2014 to July 2019) from a single centre. ESHF was defined by a diagnosis of HF prior to presentation with CS. Other causes of CS (eg: acute myocardial infarction) were excluded. We compared the clinical course, complications and 90-day survival of patients with CS due to ESHF in INTERMACS profile 1 and 2.

Results

We included 60 consecutive patients with CS due to ESHF Differences in baseline characteristics were consistent with

SUBMITTER: Lim HS 

PROVIDER: S-EPMC9125436 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature